Tahir Misbah
SEC insider (Form 3/4/5 filer). CIK 0001787359. Chief Financial Officer at Maze Therapeutics, Inc. (MAZE) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Tahir Misbah has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Officer, Chief Financial Officer
- IGM Biosciences, Inc. (IGMS): Officer, CHIEF FINANCIAL OFFICER
Tahir Misbah
CIK: 0001787359
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Mar 2, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectRestricted Stock Units
20K shares- - Mar 2, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Sep 2, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
325K shares- - Jul 23, 2025IGMS
IGM Biosciences, Inc.
SaleDirect8.7K shares at avg. $1.27$11K - Jun 16, 2025IGMS
IGM Biosciences, Inc.
SaleDirect1.5K shares at avg. $1.20$2K - Mar 14, 2025IGMS
IGM Biosciences, Inc.
SaleDirect7.3K shares at avg. $1.23$9K - Dec 16, 2024IGMS
IGM Biosciences, Inc.
SaleDirect1.7K shares at avg. $7.48$13K - Nov 18, 2024IGMS
IGM Biosciences, Inc.
AwardDirect66.7K shares- - Sep 13, 2024IGMS
IGM Biosciences, Inc.
SaleDirect1.5K shares at avg. $11.54$17K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 |  MAZE Maze Therapeutics, Inc. | Award Restricted Stock Units | 20,000 | - | - | Direct |
| Mar 2, 2026 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Sep 2, 2025 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 325,000 | - | - | Direct |
| Jul 23, 2025 |  IGMS IGM Biosciences, Inc. | Sale | 8,741 | $1.27 | $11,126 | Direct |
| Jun 16, 2025 | IGMS IGM Biosciences, Inc. | Sale | 1,522 | $1.20 | $1,825 | Direct |
| Mar 14, 2025 | IGMS IGM Biosciences, Inc. | Sale | 7,329 | $1.23 | $9,015 | Direct |
| Dec 16, 2024 | IGMS IGM Biosciences, Inc. | Sale | 1,708 | $7.48 | $12,776 | Direct |
| Nov 18, 2024 | IGMS IGM Biosciences, Inc. | Award | 66,667 | - | $0 | Direct |
| Sep 13, 2024 | IGMS IGM Biosciences, Inc. | Sale | 1,487 | $11.54 | $17,158 | Direct |
1-9 of 9 transactions